Publication | Closed Access

Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment

MedicineReceptor Tyrosine KinaseCancer GenomicsCrizotinib TreatmentCancer GeneticsSystems BiologyOncologyRadiation OncologyNovel TherapyCancer ResearchRelapsed Patients